Lack of incremental effect of histamine receptor antagonists over proton pump inhibitors on the risk of neoplastic progression in patients with Barrett's esophagus: a cohort study-Reference-Cited by-同舟云学术

Lack of incremental effect of histamine receptor antagonists over proton pump inhibitors on the risk of neoplastic progression in patients with Barrett's esophagus: a cohort study

Published:2017-03 Issue:3 Volume:18 Page:143-150
ISSN:1751-2972
Container-title:Journal of Digestive Diseases
language:en
Short-container-title:Journal of Digestive Diseases

Author:

Thota Prashanthi N¹,Hajifathalian Kaveh²,Benjamin Tanmayee¹,Runkana Ashok¹,Lopez Rocio³,Sanaka Madhusudhan R¹

Affiliation:

1. Department of Gastroenterology and Hepatology; Cleveland Clinic; Cleveland Ohio USA

2. Department of Internal Medicine; Cleveland Clinic; Cleveland Ohio USA

3. Department of Quantitative Health Sciences; Cleveland Clinic; Cleveland Ohio USA

Publisher

Wiley

Subject

Gastroenterology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1751-2980.12457/fullpdf

Reference29 articles.

1. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus;Souza;Gastroenterology,2002

2. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma;Lagergren;N Engl J Med,1999

3. Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model;Fitzgerald;J Clin Invest,1996

4. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression;Ouatu-Lascar;Gastroenterology,1999

5. The effect of antireflux surgery on esophageal carcinogenesis in patients with Barrett esophagus: a systematic review;Chang;Ann Surg,2007

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic Review and Meta-analysis of the Relationship Between Proton Pump Inhibitors and Esophageal Adenocarcinoma;Current Drug Research Reviews;2023-11

2. Assessment of the Relationship Between Gastric-Acid Suppressants and the Risk of Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis;Current Therapeutic Research;2023

3. Possible Association between the Use of Proton Pump Inhibitors and H2 Receptor Antagonists, and Esophageal Cancer: A Nested Case–Control Study Using a Korean National Health Screening Cohort;Pharmaceuticals;2022-04-22

4. Proton pump inhibitors may reduce the risk of high-grade dysplasia and/or esophageal adenocarcinoma in Barrett’s esophagus: a systematic review and meta-analysis;Expert Review of Clinical Pharmacology;2021-11-27

5. Risk of esophageal adenocarcinoma in patients with Barrett’s esophagus using proton pump inhibitors: a systematic review with meta-analysis and sequential trial analysis;Translational Cancer Research;2021-04